$8.82-0.28 (-3.08%)
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
LeonaBio, Inc. in the Healthcare sector is trading at $8.82. The stock is currently 38% below its 52-week high of $14.21, remaining 59.5% above its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why LONA maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is ...